Potential of Metatron Hunter 4025

Potential of Metatron Hunter 4025

The 3D NLS method was developed in 2006 and can play an important role in the diagnosis of vascular pathology. The main advantages of the 3D NLS method are that it is easy to search, easy to locate blood vessels and can easily distinguish vascular from non-vascular structures, arteries from veins, and very accurately reveal signs of vascular permeability disturbances caused by stenosis or occlusion of atherosclerosis Plaque or thrombosis of the vessel lumen, usually not visible with conventional angiography alone.

The 3D NLS method of the Metatron Hunter 4025 can diagnose portal hypertension, the degree of portal hypertension, and the permeability of the portal shunt. NLS is very sensitive in determining the extent of peripancreatic vascular involvement in pancreatic cancer, which is critical for the selection of surgical treatment strategies. NLS can identify affected renal vessels (venous and arterial), which is important for the correct selection of antihypertensive drugs in the setting of arterial hypertension.

The 3D NLS approach is essential for the differential diagnosis of benign and malignant liver diseases. Its sensitivity is comparable to the potential of conventional or digital angiography and magnifying CT. Also, NLS methods are cheaper, simpler and easier to use. If desired, it can be used directly at the patient's bedside.

The 3D NLS approach can be used in ophthalmology to examine ocular hemodynamics before and after surgical intervention, and in obstetrics to reveal disturbed blood flow in the umbilical artery to diagnose fetal developmental delay and predict adverse perinatal outcomes.

Another potential of the 3D NLS approach is skull scans, which can reveal intracranial hematomas, aneurysms, cysts and tumors in the brain.

The Metatron Hunter 4025 is one of the most dynamic and innovative devices and will continue to explore more possibilities in the future.